FDA
-
-
-
-
-
-
-
ARCA biopharma Reports Topline Results for ASPEN-COVID-19 Phase 2b Clinical Trial
-
-
-
-
-
-
-
ARCA biopharma Announces Enrollment of First International Patient in Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19
-
-
-
-
-
-
-
ARCA biopharma Provides Update on ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19
-
-
-
-
-
-
-
ARCA biopharma Announces 2020 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
ARCA biopharma Announces Promotion of Chief Medical Officer and Vice President, Regulatory Affairs & Quality
-
-
-
-
-
-
-
ARCA biopharma Announces Closing of $6.1 Million Registered Direct Offering
-
-
-
-
-
-
-
Clinical Data Evaluating Gencaro for the Treatment of Atrial Fibrillation in Heart Failure Patients Featured in Three Presentations at the 2020 Heart Rhythm Scientific Sessions
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

